Navigation Links
Nelson Laboratories to Present Latest FDA Trends at MEDevice Forum San Diego
Date:9/5/2012

SALT LAKE CITY, Sept. 5, 2012 /PRNewswire/ -- Nelson Laboratories' (www.nelsonlabs.com) biocompatibility specialist Thor Rollins will present the latest FDA trends impacting implantable devices to help medical device manufacturers make the best product testing decisions at MEDevice Forum San Diego, Sept. 19-20 at the San Diego Convention Center.

(Logo: http://photos.prnewswire.com/prnh/20120727/LA47745LOGO)

"There are new tests being considered according to the ISO 10993 update that medical device manufacturers need to be prepared for," said Rollins. "Manufacturers that attend the Nelson Laboratories presentations will learn the purpose behind the updates. Although the new standards are not official, the information gives you insight on the current thinking from regulatory agencies."

Watch a 3-minute video on the ISO 10993 update.

Rollins will be at the Second Annual Design of Implantable Device Conference within MEDevice Forum San Diego to present Establishing Implantable Devices as a Distinctive Subcategory with Specific Regulatory, Reliability and Test Concerns According to ISO 10993 on Wednesday, Sept. 19 at 1:30 p.m. The presentation will teach manufacturers how to:

  • Select tests for interactions with blood
  • Evaluate tests for genotoxicity, carcinogenicity and reproductive toxicity, specifically, hemocompatibility and when to perform the direct and indirect methods.
  • Understand the complement activation test
  • Examine the issues and solutions around in vivo and in vitro test methods

Rollins will also present FDA Trends Impacting Hemocompatibility & Genotoxicity, Including an ISO 10993 Update at the Innovation Briefs Theater in booth #537 on Wednesday, Sept. 19 at 12:00 p.m.

Conference attendees that would like to speak to a Nelson Laboratories representative may stop by booth #302 to ask any questions about these presentations or other medical device testing topics.

About Nelson Laboratories

Nelson Laboratories is a leading provider of full, life-cycle microbiology testing services. We are known for exceptional quality, but we look beyond the testing process and partner with you to achieve your long-term business goals. It's what we call The Science of Success™. It's transparency in the testing process. It's approachable experts that guide you through ever-changing compliance requirements. It's helping you mitigate risk, be first to market, and succeed with your customers. Learn more at www.nelsonlabs.com.

PR Contact:

Ryan Oaks
Snapp Conner PR
801-994-9625
ryan@snappconner.com


'/>"/>
SOURCE Nelson Laboratories
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
2. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
3. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
4. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
5. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
6. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
7. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
8. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
9. Court Preliminarily Deems Millennium Laboratories Press Release Misleading
10. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
11. Carl Icahn Issues Letter To Howard Solomon Of Forest Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... N.J. , April 28, 2016   Acsis ... today announced that leading IT market research and advisory ... " in the IDC MarketScape: Worldwide Pharmaceutical Track and ... 2016).  The report provides an assessment of the capabilities ... track and trace software market. Logo - ...
(Date:4/28/2016)... PUNE, India , April 28, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" is a report ... pipeline and helps strengthen R&D pipelines by identifying ... best-in-class products. Company Profiles discussed in ... Menarini Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen ...
Breaking Medicine Technology:
(Date:4/29/2016)... STAMFORD, CONNECTICUT (PRWEB) , ... April 29, 2016 , ... ... 5K Run/Walk” at Cove Island Park on Sunday, with sunny skies, a light breeze ... event, raising nearly $33,000. , The 5k Run and Walk and 1-mile ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... announced that student team BioCellection won the $30,000 Perlman Grand Prize of the 2016 ... the Gloeckner Undergraduate Award, the Michelson People’s Choice Award, and the Committee Award ...
(Date:4/29/2016)... ... ... is the deadliest type of skin cancer. Although only about 1 percent of skin cancer ... than 10,000 people are expected to die of melanoma this year. The risk increases with ... the most commonly diagnosed cancers in young women. A recent breakthrough in genetic studies may ...
(Date:4/29/2016)... ... , ... For those who skip meals occasionally (which is pretty much everyone), ... many new lifestyle diet tips offered by nutritionists Pam Bonney and Priya Lawrence of ... show. Bonny and Lawrence noted that because proper nutrition, including water, provides energy during ...
(Date:4/29/2016)... N.J. (PRWEB) , ... April 29, 2016 , ... ... digital and print media enterprise focused entirely on patients with cancer, today announced ... California, was chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing ...
Breaking Medicine News(10 mins):